Decellularized esophageal tubular scaffold microperforated by quantum molecular resonance technology and seeded with mesenchymal stromal cells for tissue engineering esophageal regeneration.
esophagus
mesenchymal stromal cells
quantum molecular resonance
scaffold
tissue engineering
Journal
Frontiers in bioengineering and biotechnology
ISSN: 2296-4185
Titre abrégé: Front Bioeng Biotechnol
Pays: Switzerland
ID NLM: 101632513
Informations de publication
Date de publication:
2022
2022
Historique:
received:
04
04
2022
accepted:
17
08
2022
entrez:
21
10
2022
pubmed:
22
10
2022
medline:
22
10
2022
Statut:
epublish
Résumé
Current surgical options for patients requiring esophageal replacement suffer from several limitations and do not assure a satisfactory quality of life. Tissue engineering techniques for the creation of customized "self-developing" esophageal substitutes, which are obtained by seeding autologous cells on artificial or natural scaffolds, allow simplifying surgical procedures and achieving good clinical outcomes. In this context, an appealing approach is based on the exploitation of decellularized tissues as biological matrices to be colonized by the appropriate cell types to regenerate the desired organs. With specific regard to the esophagus, the presence of a thick connective texture in the decellularized scaffold hampers an adequate penetration and spatial distribution of cells. In the present work, the Quantum Molecular Resonance
Identifiants
pubmed: 36267444
doi: 10.3389/fbioe.2022.912617
pii: 912617
pmc: PMC9576845
doi:
Types de publication
Journal Article
Langues
eng
Pagination
912617Informations de copyright
Copyright © 2022 Marzaro, Pozzato, Tedesco, Algeri, Pozzato, Tomao, Montano, Torroni, Balassone, Contini, Guerra, D’Angelo, Federici di Abriola, Lupoi, Caristo, Boškoski, Costamagna, Francalanci, Astori, Bozza, Bagno, Todesco, Trovalusci, Oglio, Locatelli and Caldaro.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
J Tissue Eng. 2020 Jul 22;11:2041731420942903
pubmed: 32742632
J Surg Res. 2005 Sep;128(1):87-97
pubmed: 15922361
Ann Surg. 1986 Apr;203(4):346-51
pubmed: 3963894
Biomaterials. 2016 Jun;92:1-12
pubmed: 27031928
Front Immunol. 2014 May 19;5:148
pubmed: 24904568
Semin Immunol. 2008 Apr;20(2):86-100
pubmed: 18162407
Carbohydr Polym. 2021 Jun 1;261:117846
pubmed: 33766342
J Pediatr Surg. 2000 Jul;35(7):1097-103
pubmed: 10917304
Anat Rec. 2001 Aug 1;263(4):372-8
pubmed: 11500814
J Pediatr Surg. 2001 Feb;36(2):266-8
pubmed: 11172413
Eur Spine J. 2008 Dec;17 Suppl 4:467-79
pubmed: 19005702
Nat Commun. 2018 Oct 16;9(1):4286
pubmed: 30327457
Lancet. 2016 Jul 2;388(10039):55-61
pubmed: 27068836
Surgery. 2015 Jul;158(1):266-77
pubmed: 25796416
Bioengineering (Basel). 2020 Mar 31;7(2):
pubmed: 32244491
Int J Mol Med. 2002 Aug;10(2):177-82
pubmed: 12119555
Curr Opin Otolaryngol Head Neck Surg. 2015 Dec;23(6):423-32
pubmed: 26371603
Life Sci. 1975 Dec 1;17(11):1721-32
pubmed: 1207385
Semin Pediatr Surg. 2017 Apr;26(2):95-104
pubmed: 28550877
Sci Rep. 2020 Apr 29;10(1):7255
pubmed: 32350326
Sci Rep. 2018 Mar 7;8(1):4123
pubmed: 29515136
Tissue Eng Part A. 2011 Jun;17(11-12):1643-50
pubmed: 21306292
Tissue Eng Part B Rev. 2013 Dec;19(6):485-502
pubmed: 23672709
Cell Transplant. 2017 Dec;26(12):1831-1839
pubmed: 29390879
ASAIO J. 2001 Jul-Aug;47(4):342-5
pubmed: 11482483
J Thorac Cardiovasc Surg. 1982 Jun;83(6):918-27
pubmed: 7087521
Eur J Pediatr Surg. 1995 Aug;5(4):206-10
pubmed: 7577857
PLoS One. 2018 Nov 8;13(11):e0206811
pubmed: 30408051
Ann Surg. 1988 May;207(5):590-7
pubmed: 3288139
Biomaterials. 2005 May;26(15):2567-74
pubmed: 15585259
Tissue Eng Part A. 2019 Mar;25(5-6):487-498
pubmed: 30259795
Cell Mol Gastroenterol Hepatol. 2017 Sep 14;5(1):1-13
pubmed: 29276748
Eur Surg Res. 2003 Jul-Aug;35(4):372-6
pubmed: 12802099
J Paediatr Child Health. 2017 Dec;53(12):1159-1166
pubmed: 28799279
J Surg Res. 2013 Jun 1;182(1):40-8
pubmed: 22925499
J Pediatr Surg. 1984 Apr;19(2):149-54
pubmed: 6726567
J Pediatr Surg. 2003 Jan;38(1):53-7; discussion 53-7
pubmed: 12592618
Bioact Mater. 2020 Jan 08;5(1):1-8
pubmed: 31938756
Tissue Eng Part A. 2015 Feb;21(3-4):486-97
pubmed: 25203687
Semin Immunol. 2008 Apr;20(2):109-16
pubmed: 18083531
Dig Surg. 2007;24(2):88-95
pubmed: 17446703
Ann Thorac Surg. 2013 Mar;95(3):1096-7
pubmed: 23438545
J Biomed Mater Res A. 2006 Jun 15;77(4):795-801
pubmed: 16575908
Biomaterials. 2019 Feb;192:405-415
pubmed: 30500722
Lancet. 2017 May 20;389(10083):2041-2052
pubmed: 28045663
World J Gastroenterol. 2012 Dec 21;18(47):6900-7
pubmed: 23322987
Am J Gastroenterol. 1999 Jun;94(6):1490-6
pubmed: 10364012
Acta Biomater. 2013 Dec;9(12):9379-91
pubmed: 23933485
F1000Res. 2020 Feb 27;9:
pubmed: 32148780
Pediatr Surg Int. 2007 Jan;23(1):21-6
pubmed: 17004093
Br J Surg. 2006 Mar;93(3):282-90
pubmed: 16498591
World J Gastroenterol. 2012 Oct 28;18(40):5679-87
pubmed: 23155307
J Tissue Eng Regen Med. 2015 May;9(5):504-11
pubmed: 24668694
Lancet Oncol. 2007 Jun;8(6):545-53
pubmed: 17540306
Ann Thorac Surg. 2014 Jan;97(1):283-8
pubmed: 24266951
Sci Adv. 2020 Jul 01;6(27):eaba4526
pubmed: 32656339
J Hematother. 1996 Feb;5(1):15-23
pubmed: 8646477
ASAIO J. 1999 Sep-Oct;45(5):502-8
pubmed: 10503633
Biomaterials. 2011 Apr;32(12):3233-43
pubmed: 21296410
J Pediatr Surg. 2004 Jul;39(7):1084-90
pubmed: 15213904
Biomaterials. 2015 Jul;57:133-41
pubmed: 25916501
Tissue Eng Part A. 2015 Sep;21(17-18):2293-300
pubmed: 26192009
Nat Commun. 2019 Oct 11;10(1):4620
pubmed: 31604958
Surg Oncol Clin N Am. 1999 Apr;8(2):279-94
pubmed: 10339646
Therap Adv Gastroenterol. 2020 May 26;13:1756284820923220
pubmed: 32523626
Front Immunol. 2012 Sep 26;3:297
pubmed: 23056000
Int J Mol Sci. 2018 Apr 28;19(5):
pubmed: 29710813
Int J Mol Med. 2021 Feb;47(2):463-474
pubmed: 33416123
Int J Mol Sci. 2019 Feb 01;20(3):
pubmed: 30717232
Surgeon. 2008 Feb;6(1):54-6
pubmed: 18318090
Nat Mater. 2005 Jul;4(7):518-24
pubmed: 16003400